FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection

Signal Transduct Target Ther. 2023 Mar 21;8(1):135. doi: 10.1038/s41392-023-01390-y.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • COVID-19* / prevention & control
  • Chlorocebus aethiops
  • Fragile X Mental Retardation Protein / metabolism
  • SARS-CoV-2
  • Vero Cells

Substances

  • Antiviral Agents
  • Fragile X Mental Retardation Protein